FUNDACION PARA LA INVESTIGACION MEDICA APLICADA FIMA
- Country
- Spain
- Type
- Beneficiary
- Website
- www.cima.es
- Grants received
- 41
Funding record
- 41 grants on record
- €17,346,139.43 awarded in total
- 2008–2024 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
- Seventh Framework Programme
- Horizon Europe Framework Programme
- European Research Council
- Horizon 2020 Framework Programme
20 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- UNIVERSIDAD DE NAVARRA
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- UNIVERSITEIT MAASTRICHT
- ACADEMISCH ZIEKENHUIS LEIDEN
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
- INSERM TRANSFERT SA
- KATHOLIEKE UNIVERSITEIT LEUVEN
- MEDIZINISCHE HOCHSCHULE HANNOVER
Calls from this organisation
No published calls from this organisation.
Grants received
- RNA-based cancer ImmunotheraPeutics to Enhance CROssPrimming
- SPatial Analysis of Cancer Evolution in the Tumour Immune MicroEnvironment
- Artificial induction of tertiary lymphoid structures (TLS) in tumors using intratumoral mRNAs to evaluate its synergy with immune checkpoint inhibitors
- Dissecting the role of the immune microenvironment in the onset of myelodysplastic syndromes
- Exploiting single cell long non-coding RNA biology to target therapy-induced senescence in lung cancer
- AI-enabled RNA nanotechnology DElivery SysTem for INformATION transfer into cells.
- Synapses between Leukaemia and its Neighbouring Cells
- DevelOpmeNt of Cancer RNA TherapEutics
- Elucidating transcriptional rewiring on hematological malignancies via computational methods
- MiCrovasculaR rarefaction in vascUlar Cognitive Impairement and heArt faiLure
- COMORBIDITY MECHANISMS OF ANXIETY AND PARKINSON’S DISEASE
- Training Network for the education of the next generation scientist in targeting the supressive capacity of regulatory T-cells specifically within tumours
- Investigating the role of the long noncoding transcriptome in chromatin replication
- Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers
- European Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale Geometry
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.